Neuropsychiatric adverse effects of antiparkinsonian drugs : Characteristics, evaluation and treatment

Parkinson's disease (PD) is a progressive neurological condition that causes considerable disability in the elderly. Drugs used to treat PD, such as levodopa, offer symptomatic relief but often have neuropsychiatric adverse effects, most prominently psychosis and delirium. Aged patients and tho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs & aging 1997-05, Vol.10 (5), p.367-383
Hauptverfasser:	YOUNG, B. K, CAMICIOLI, R, GANZINI, L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aging - pathology Akathisia, Drug-Induced - drug therapy Akathisia, Drug-Induced - therapy Amantadine - adverse effects Antiparkinson Agents - adverse effects Antipsychotic Agents - administration & dosage Antipsychotic Agents - therapeutic use Biological and medical sciences Cholinergic Antagonists - adverse effects Delirium - chemically induced Delirium - drug therapy Delirium - therapy Dementia - chemically induced Dementia - drug therapy Dementia - therapy Depression - chemically induced Depression - drug therapy Depression - therapy Dopamine Agonists - adverse effects Drug toxicity and drugs side effects treatment Electroconvulsive Therapy Humans Levodopa - adverse effects Medical sciences Memantine - adverse effects Monoamine Oxidase Inhibitors - adverse effects Pharmacology. Drug treatments Psychoses, Substance-Induced - drug therapy Psychoses, Substance-Induced - therapy Risk Factors Serotonin Antagonists - administration & dosage Serotonin Antagonists - therapeutic use Toxicity: nervous system and muscle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!